Augmedix
More actions
| Augmedix | |
|---|---|
| Information | |
| Type | Subsidiary |
| Industry | Healthcare technology, medical documentation |
| Founded | 2012 |
| Founder | Ian Shakil, Pelu Tran |
| Headquarters | San Francisco, California, United States |
| Notable Personnel | Ian Shakil (founder; CEO 2013-2018), Pelu Tran (co-founder), Emmanuel "Manny" Krakaris (CEO, appointed October 2018) |
| Products | Augmedix Live, Augmedix Go, Augmedix Assist (formerly Augmedix Notes) |
| Parent | Commure (from October 2024) |
| Website | https://www.augmedix.com |
Augmedix is an American medical documentation company based in San Francisco. It was co-founded in 2012 by Ian Shakil and Pelu Tran, then a Stanford medical student. Its first product used Google Glass: doctors wore Glass during patient visits and streamed the conversation to remote scribes, who wrote the visit note into the patient's electronic health record.[1] Alphabet's X named Augmedix as a partner when it introduced Google Glass Enterprise Edition in July 2017.[2]
The company later moved most clinicians to smartphones and added automated note generation. By early 2023 about 5% of its clinicians used Google Glass, and after Google ended Glass Enterprise Edition it said it would move those users to other hardware.[3] Augmedix became a public company through a reverse merger in 2020 and listed on the Nasdaq Capital Market in October 2021. Commure, a healthcare technology company based in Mountain View, California, acquired it in an all-cash deal that closed on 2 October 2024, and Augmedix now operates as a wholly owned Commure subsidiary.[4]
History
Founding and Google Glass
Shakil and Tran met as students in a Biodesign class at Stanford University. Tran had an undergraduate degree in mechanical engineering from Stanford and took the course in his second year of medical school; Shakil was a Stanford MBA graduate. According to Tran, the two tried a prototype of Google Glass one morning and decided it could be useful in health care. The pair co-founded Augmedix in late summer 2012, and Tran took a leave of absence from medical school in spring 2013 to work on the company full time.[1] The company's later securities filings give 2013 as its year of incorporation and 2014 as the year it launched its commercial real-time remote documentation service.[5] Shakil was chief executive officer from April 2013 to October 2018.[6]
In August 2014, Thalmic Labs named Augmedix as one of the enterprise partners for its Myo armband. TechCrunch reported that Myo let physicians navigate the Augmedix Glass system without speaking to Glass or touching the headset's touchpad.[7]
In January 2015 Augmedix raised a 16 million US dollar Series A round co-led by its seed investors, Emergence Capital and DCM Ventures. TechCrunch put its total funding at more than 23 million US dollars, including a 7.3 million dollar seed round raised in 2014, and reported deployments in 10 US states and more than 100 employees, 80 of them at the San Francisco headquarters.[8] When Google stopped selling Glass to consumers in early 2015, Stanford Medicine reported that Google would continue to contract use of the technology with companies such as Augmedix. Tran said at the time that the service was used in 35 clinics across 11 states and that 99 percent of patients asked at the front desk agreed to its use.[1]
Funding from health systems
In April 2016 Augmedix closed a 17 million US dollar round led by Redmile Group, with Emergence and DCM taking part. Health systems Sutter Health, Dignity Health, Catholic Health Initiatives and TriHealth contributed to that round.[9][10] In December 2016 it raised a further 23 million US dollars from investors including McKesson Ventures and OrbiMed, alongside Redmile, Emergence and DCM. Global Venturing reported that this brought its total funding to more than 60 million US dollars.[9]
Glass Enterprise Edition
On 18 July 2017, Jay Kothari, project lead for Glass Enterprise at X, announced that Glass Enterprise Edition would be sold to more businesses through a partner network. The post described doctors at Dignity Health using Glass with an application that "our partner Augmedix calls 'a remote scribe'". It quoted Dignity's chief medical information officer, Davin Lundquist, as saying that the time doctors spent on patient notes and other administrative work fell from 33 percent of their day to less than 10 percent. It also cited Albert Chan of Sutter Health, where doctors used Glass with Augmedix.[2] MedCity News reported the same month that Shakil had named TriHealth, Catholic Health Initiatives, Eastern Maine Medical Center and Christiana Care as other health systems using Glass Enterprise Edition with Augmedix.[10] STAT reported in August 2017 that the company said doctors and health systems in 30 states were using its product.[11]
Leadership change and public listing
Emmanuel "Manny" Krakaris became president and chief executive officer in October 2018. He had advised the board from April to May 2018 and served as chief operating officer from June to September 2018. Shakil became chief strategy officer and stayed on the board.[6]
On 5 October 2020 a subsidiary of Malo Holdings Corporation, a shell company, merged with the privately held Augmedix. The private company was renamed Augmedix Operating Corporation, and the public parent changed its name to Augmedix, Inc.[6] Its shares first traded over the counter on the OTCQX market under the symbol AUGX.[5] On 25 October 2021 the company priced a 40 million US dollar public offering of 10,000,000 shares at 4.00 US dollars each and said its stock was expected to begin trading on the Nasdaq Capital Market on 26 October 2021, replacing its over-the-counter trading.[12]
Acquisition by Commure
On 19 July 2024 Augmedix agreed to be acquired by Commure for 2.35 US dollars per share in cash, valuing the company at about 139 million US dollars in equity value.[13][14] Stockholders approved the deal on 27 September 2024, and the merger closed on 2 October 2024. Augmedix's stock stopped trading on Nasdaq that day, and the company asked Nasdaq to delist and deregister its shares.[4][15] On 23 October 2024 Commure announced that HCA Healthcare had selected it as the exclusive partner to develop and deploy an ambient AI platform, built with "the Augmedix team led by company founder Ian Shakil"; a formal enterprise agreement was still being negotiated.[16] Augmedix continued to publish news under its own name after the acquisition, including a January 2025 Vizient contract for Augmedix Go, Augmedix Assist and Augmedix Live.[17]
Products
Augmedix's services combine clinician-side software with remote staff and, in later products, automated note generation. Its 2021 prospectus calls the remote staff medical documentation specialists (MDSs); its 2020 filing used the term remote documentation specialists.[5][6] The company and its outside MDS vendors recruited MDSs in the United States, Bangladesh, India and Sri Lanka.[5]
| Product | Description | Source |
|---|---|---|
| Augmedix Live | Real-time remote documentation. An MDS watches the visit through an audio and video stream, writes the note and gives live clinical support. In 2021 clinicians could connect with a smartphone or a Google Glass unit owned and managed by Augmedix. | [5] |
| Augmedix Notes (later Augmedix Go Assist / Augmedix Assist) | Non-real-time documentation from recorded visits, launched in mid-2020. Clinicians recorded on a smartphone; Glass was not offered for this service. Marketed as Augmedix Assist by January 2025. | [5][17][18] |
| Augmedix Go | Mobile app that generates notes with the company's AI without MDS review, for the clinician to approve in the health record. Generally available for ambulatory care in December 2023. | [18] |
XR work
Augmedix used Google Glass as a head-worn camera, microphone and small display. Stanford Medicine described doctors wearing Glass, which was supplied on a monthly subscription, during appointments. Voice commands let them pull up a patient's records on the small screen in the corner of the right eye, while the camera and microphone streamed the visit to Augmedix staff, who used a mix of software and human work to write the note.[1] STAT described the same setup as letting doctors view charts through the eyepiece while facing their patients.[11] In the company's 2021 prospectus, its "Doc App" ran as a standalone Android app on both smartphones and Google Glass and handled secure streaming and instant messaging between the clinician and the MDS.[5]
By February 2015 Augmedix had been using Glass in doctors' offices for about a year and a half, and in 2017 it was one of the healthcare partners named in X's Google Glass Enterprise Edition announcement.[1][2] Google stopped selling Glass Enterprise Edition on 15 March 2023 and ended support on 15 September 2023.[19] In its annual report for 2022, filed in April 2023, Augmedix said about 5% of its clinicians used Google Glass and that it would move them to other hardware, such as a mobile device with a lapel microphone.[3] Its report for 2023 described the clinician device as mainly a smartphone running Android or iOS apps and said it was still looking at other hardware for clinicians.[18]
See also
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Tracie White (2015-02-09). "Medical student's startup uses Google Glass to improve patient-physician relationship". Stanford Medicine News Center. https://med.stanford.edu/news/all-news/2015/02/medical-students-startup-uses-google-glass.html. Retrieved 2026-10-21.
- ↑ 2.0 2.1 2.2 Jay Kothari (2017-07-18). "A New Chapter for Glass". X. https://x.company/blog/posts/a-new-chapter-for-glass/. Retrieved 2026-10-21.
- ↑ 3.0 3.1 "Augmedix, Inc. Form 10-K for the fiscal year ended December 31, 2022". U.S. Securities and Exchange Commission. Augmedix, Inc.. 2023-04-17. https://www.sec.gov/Archives/edgar/data/1769804/000121390023030004/f10k2022_augmedixinc.htm. Retrieved 2026-10-21.
- ↑ 4.0 4.1 "Commure Completes Merger with Augmedix". U.S. Securities and Exchange Commission. Commure (Exhibit 99.1 to Augmedix Form 8-K). 2024-10-02. https://www.sec.gov/Archives/edgar/data/1769804/000119312524230765/d875756dex991.htm. Retrieved 2026-10-21.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 "Augmedix, Inc. Prospectus (Form 424B4)". U.S. Securities and Exchange Commission. Augmedix, Inc.. 2021-10-28. https://www.sec.gov/Archives/edgar/data/1769804/000121390021054916/f424b41021_augmedix.htm. Retrieved 2026-10-21.
- ↑ 6.0 6.1 6.2 6.3 "Augmedix, Inc. (formerly Malo Holdings Corporation) Form 8-K". U.S. Securities and Exchange Commission. Augmedix, Inc.. 2020-10-09. https://www.sec.gov/Archives/edgar/data/1769804/000121390020030762/ea127438-8k_malohold.htm. Retrieved 2026-10-21.
- ↑ Darrell Etherington (2014-08-19). "Thalmic Reveals Its Enterprise Play For the Myo Armband, Including Google Glass Integration". TechCrunch. https://techcrunch.com/2014/08/19/thalmic-reveals-its-enterprise-play-for-the-myo-armband-including-google-glass-integration/. Retrieved 2026-10-21.
- ↑ Darrell Etherington (2015-01-12). "Fresh Funding For Augmedix Suggests Your Doctor Could Soon Be Wearing Google Glass". TechCrunch. https://techcrunch.com/2015/01/12/fresh-funding-for-augmedix-suggests-your-doctor-could-soon-be-wearing-google-glass/. Retrieved 2026-10-21.
- ↑ 9.0 9.1 Thierry Heles (2016-12-09). "Augmedix documents $23m investment". Global Venturing. https://globalventuring.com/augmedix-documents-23m-investment. Retrieved 2026-10-21.
- ↑ 10.0 10.1 Erin Dietsche (2017-07-23). "Google Glass gains headway in healthcare". MedCity News. https://medcitynews.com/2017/07/google-glass-healthcare/. Retrieved 2026-10-21.
- ↑ 11.0 11.1 Charles Piller (2017-08-29). "Google Glass is back as a tool to coach autistic children - and much more". STAT. https://www.statnews.com/2017/08/29/google-glass-health-care/. Retrieved 2026-10-21.
- ↑ "Augmedix, Inc. Announces Uplisting to Nasdaq and Pricing of Public Offering of $40,000,000 of Common Stock". U.S. Securities and Exchange Commission. Augmedix, Inc. (Exhibit 99.1 to Form 8-K). 2021-10-25. https://www.sec.gov/Archives/edgar/data/1769804/000121390021054520/ea148554ex99-1_augmedix.htm. Retrieved 2026-10-21.
- ↑ "Augmedix to Join Forces with Commure". U.S. Securities and Exchange Commission. Augmedix, Inc. (Exhibit 99.1 to Form 8-K). 2024-07-19. https://www.sec.gov/Archives/edgar/data/1769804/000121390024062747/ea020961401ex99-1_augmedix.htm. Retrieved 2026-10-21.
- ↑ Emily Olsen (2024-07-22). "Commure to acquire AI scribe Augmedix in $139M deal". Healthcare Dive. https://www.healthcaredive.com/news/commure-acquire-augmedix-ai-documentation/721978/. Retrieved 2026-10-21.
- ↑ "Augmedix, Inc. Form 8-K (completion of merger)". U.S. Securities and Exchange Commission. Augmedix, Inc.. 2024-10-02. https://www.sec.gov/Archives/edgar/data/1769804/000119312524230765/d875756d8k.htm. Retrieved 2026-10-21.
- ↑ "Commure To Partner with HCA Healthcare on Ambient AI Platform". Commure. 2024-10-23. https://www.commure.com/press-releases/hca-and-commure-announce-largest-ai-deployment-in-healthcare. Retrieved 2026-10-21.
- ↑ 17.0 17.1 "Resources". Augmedix. https://www.augmedix.com/resources-new. Retrieved 2026-10-21.
- ↑ 18.0 18.1 18.2 "Augmedix, Inc. Form 10-K for the fiscal year ended December 31, 2023". U.S. Securities and Exchange Commission. Augmedix, Inc.. 2024-03-26. https://www.sec.gov/Archives/edgar/data/1769804/000162828024013117/augx-20231231.htm. Retrieved 2026-10-21.
- ↑ "Glass Enterprise Edition Announcement FAQ". Glass Enterprise Edition Help. Google. 2023-03-15. https://support.google.com/glass-enterprise/customer/answer/13417888?hl=en. Retrieved 2026-10-21.